Jamie Murphy
Comptroller/Controller/Auditor chez SIGILON THERAPEUTICS, INC.
Profil
Jamie Murphy is currently the Vice President-Finance & Controller at Sigilon Therapeutics, Inc. Prior to this, he worked as a Controller at Zafgen, Inc. and as a Financial Consultant at Larimar Therapeutics, Inc. Mr. Murphy completed his undergraduate degree at Wake Forest University and his graduate studies, including an MBA, at Northeastern University.
Postes actifs de Jamie Murphy
| Sociétés | Poste | Début |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Anciens postes connus de Jamie Murphy
| Sociétés | Poste | Fin |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| LARIMAR THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Formation de Jamie Murphy
| Wake Forest University | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| LARIMAR THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
